Claya Review

The membership is the product, and it says so

Ask most sellers here whether the price includes the drug and you get silence. Claya answers in a sentence: the membership fee includes access to reduced-price GLP-1 medications and personalised care coaching, but the medication is not included in the fee. You will, it adds, receive your medications at a steeply discounted price.

That is the clearest statement of a split bill on this roster, and it matters more than it sounds, because a reader comparing a membership figure here against a flat monthly figure elsewhere is comparing a fraction of a bill against a whole one. Our record keeps the two apart deliberately: the medication figures sit on the price rows and the membership sits in its own field, so any tool that adds them has to add them on purpose.

What undermines it is that the fee itself is published twice, at two different amounts. The FAQ on the weight-loss page answers the question directly with one figure. The treatment card that renders on every single product page shows a lower one. Both were live in the same reading. Our row carries the higher of the two, because that is the number a reader is less likely to be unpleasantly surprised by, and the contradiction travels with it.

Two pharmacies, with addresses you can dial

At the foot of the Terms, under a heading that reads Partner Pharmacies, there are two entries. Each has a legal name, a street address, a telephone number and a website: one in St. George, Utah, one in Florence, Kentucky. The same block repeats in the site footer on every page we read.

This is the most complete pharmacy disclosure in this comparison. Ondra Health names six with their regulatory classes, which is broader; Claya's is deeper, because you could verify these two against a state board or simply call them. Set against that, the Terms also say the company is not acting as a pharmacy, does not control how medication is provided, and does not endorse any specific pharmacy — a disclaimer that sits oddly beside a list of the two it uses.

The prescribing side is not disclosed the same way. An our-approach page introduces a medical advisory team of two, one a naturopathic doctor specialising in metabolic health, the other a cardiologist with a long string of fellowships. The heading calls them experts who support your journey. The Terms describe the people who will actually write your prescription only as licensed physicians, medical providers and other clinicians employed or contracted by unnamed medical groups. Two names is better than none; neither of them is your prescriber.

A brand pen and a compounded vial on the same card

Every weight-loss page here carries the same five-card block: a brand-name tirzepatide pen, a compounded semaglutide injection, compounded semaglutide tablets, a brand-name semaglutide pen, a second brand-name tirzepatide pen, and the membership. All six priced, all six on one screen.

That layout does something the rest of this roster mostly avoids, which is put a four-figure brand price directly beside a three-figure compounded one and let the reader draw the conclusion. Bon Health publishes both too, but its brand page is badged Coming Soon. Here both routes have live start buttons.

The site is also careful in a way that is worth crediting. Beneath the trial statistics on every product page it prints a line stating that those studies evaluated the manufacturer-developed, FDA-approved products and did not assess compounded semaglutide or compounded tirzepatide. Sellers routinely borrow brand trial numbers for compounded products without saying that. This one says it, on the same page, in the same block.

Less careful: the compounded semaglutide card describes the product as having the same active ingredient as Ozempic and Wegovy. The FDA quoted that exact construction in a September 2025 warning letter to Lovely Meds, also reviewed here, saying it implies a compounded product is the same as an FDA-approved one when it is not. We searched FDA's live warning-letter record for this company's legal entity and its brand name on the day this review was written, with a positive and a negative control in the same run, and found no letter to either. That is a fact about the wording, not an accusation about this seller.

Fifty states, then forty-nine

The Terms open by saying the site and services are available in all fifty states plus the District of Columbia. Further down the same document, in capital letters, they say that because of Louisiana law the third-party partner pharmacies cannot provide compounded GLP-1 medications to residents of Louisiana. The seller's own typo is in that sentence, which is a fair indication of how recently anyone read it.

Both statements are true of different things — the platform is available everywhere, the compounded drugs are not — but a reader in Louisiana meets the fifty-state claim first and the exclusion only if they read the Terms to the end. Our row records the narrower list, the way we record Direct Meds' two excluded states, because the compounded lane is what most readers arrive for and nobody should be told this seller serves them when its own pharmacies cannot.

One more artefact in the same footer: the copyright line reads Copyright, the symbol, and then the literal word year in square brackets. It is an unfilled template token, and it renders on the terms page, the weight-loss page and every product page we opened.

What as low as is hiding

Not one medication figure on this site is a settled price. Every card says as low as, and none of them states a dose, a quantity, a vial size or a plan length beside the number. So the compounded semaglutide figure could be the starting dose or the maintenance dose, a month's supply or a first fill, and the page does not say.

The brand pens have the same problem in a more expensive form. A brand-name figure quoted as low as, with no dose stated, is a number that can only go up — brand GLP-1 pricing is per strength, and the lowest strength is the cheapest.

The first-month promotion is published as an amount off with a coupon code, never as a resulting price. Our row carries no introductory rate for that reason: subtracting a coupon from an as-low-as figure would print a number this seller has never printed.

The company behind all of this is Scrappy Scripts, Inc., a Delaware corporation doing business as Claya.com, named in the first sentence of the Terms. Brand name and legal name share nothing, which is worth knowing if you ever need to look the company up.